Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 9672082, 10 pages
http://dx.doi.org/10.1155/2016/9672082
Research Article

Quiescent and Active Tear Protein Profiles to Predict Vernal Keratoconjunctivitis Reactivation

1IRCCS-G.B. Bietti Foundation, 00100 Rome, Italy
2Department of Ophthalmology, Campus Bio-Medico University, 00128 Rome, Italy
3UCL Institute of Ophthalmology, London EC1V 9EL, UK

Received 16 November 2015; Accepted 17 January 2016

Academic Editor: Sung-Hoon Kim

Copyright © 2016 Alessandra Micera et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Bonini, S. Bonini, A. Lambiase et al., “Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term followup,” Ophthalmology, vol. 107, no. 6, pp. 1157–1163, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Bonini, A. Lambiase, R. Sgrulletta, and S. Bonini, “Allergic chronic inflammation of the ocular surface in vernal keratoconjunctivitis,” Current Opinion in Allergy and Clinical Immunology, vol. 3, no. 5, pp. 381–387, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Leonardi, D. Lazzarini, L. Motterle et al., “Vernal keratoconjunctivitis-like disease in adults,” American Journal of Ophthalmology, vol. 155, no. 5, pp. 796–803, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Bonini, M. Sacchetti, F. Mantelli, and A. Lambiase, “Clinical grading of vernal keratoconjunctivitis,” Current Opinion in Allergy and Clinical Immunology, vol. 7, no. 5, pp. 436–441, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Uchio, S. Y. Ono, Z. Ikezawa et al., “Tear levels of IFN-gamma, interleukin (IL) 2, IL4 and IL5 in patients with vernal keratoconjunctivitis, atopic keratitis and allergic conjunctivitis,” Clinical & Experimental Allergy, vol. 30, no. 1, pp. 103–109, 2000. View at Google Scholar
  6. A. Leonardi, S. J. Curnow, H. Zhan, and V. L. Calder, “Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures,” Clinical and Experimental Allergy, vol. 36, no. 6, pp. 777–784, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. E. B. Cook, J. L. Stahl, L. Lowe et al., “Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergics vs. non-allergics,” Journal of Immunological Methods, vol. 254, no. 1-2, pp. 109–118, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. A. M. Abu El-Asrar, K. Geboes, S. Al-Kharashi, K. F. Tabbara, L. Missotten, and V. Desmet, “Adhesion molecules in vernal keratoconjunctivitis,” British Journal of Ophthalmology, vol. 81, no. 12, pp. 1099–1106, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Lambiase, S. Bonini, A. Micera et al., “Increased plasma levels of substance P in vernal keratoconjunctivitis,” Investigative Ophthalmology and Visual Science, vol. 38, no. 10, pp. 2161–2164, 1997. View at Google Scholar · View at Scopus
  10. A. Lambiase, E. M. Normando, L. Vitiello et al., “Natural killer cells in vernal keratoconjunctivitis,” Molecular Vision, vol. 13, pp. 1562–1567, 2007. View at Google Scholar · View at Scopus
  11. S. Bonini, A. Micera, A. Iovieno, A. Lambiase, and S. Bonini, “Expression of toll-like receptors in healthy and allergic conjunctiva,” Ophthalmology, vol. 112, no. 9, pp. 1528–1549, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Leonardi, I. A. Fregona, M. Plebani, A. G. Secchi, and V. L. Calder, “Th1- and Th2-type cytokines in chronic ocular allergy,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 244, no. 10, pp. 1240–1245, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Motterle, Y. Diebold, A. Enríquez de Salamanca et al., “Altered expression of neurotransmitter receptors and neuromediators in vernal keratoconjunctivitis,” Archives of Ophthalmology, vol. 124, no. 4, pp. 462–468, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Sack, L. Conradi, A. Beaton, S. Sathe, N. McNamara, and A. Leonardi, “Antibody array characterization of inflammatory mediators in allergic and normal tears in the open and closed eye environments,” Experimental Eye Research, vol. 85, no. 4, pp. 528–538, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Leonardi, S. Sathe, M. Bortolotti, A. Beaton, and R. Sack, “Cytokines, matrix metalloproteases, angiogenic and growth factors in tears of normal subjects and vernal keratoconjunctivitis patients,” Allergy, vol. 64, no. 5, pp. 710–717, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Leonardi, “Allergy and allergic mediators in tears,” Experimental Eye Research, vol. 117, pp. 106–117, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. M. R. Allansmith and R. N. Ross, “Ocular allergy and mast cell stabilizers,” Survey of Ophthalmology, vol. 30, no. 4, pp. 229–244, 1986. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Mantelli, M. S. Santos, T. Petitti et al., “Systematic review and meta-analysis of randomised clinical trials on topical treatments for vernal keratoconjunctivitis,” British Journal of Ophthalmology, vol. 91, no. 12, pp. 1656–1661, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Lambiase, S. Minchiotti, A. Leonardi et al., “Prospective, multicenter demographic and epidemiological study on vernal keratoconjunctivitis: a glimpse of ocular surface in Italian population,” Ophthalmic Epidemiology, vol. 16, no. 1, pp. 38–41, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Inic-Kanada, A. Nussbaumer, J. Montanaro et al., “Comparison of ophthalmic sponges and extraction buffers for quantifying cytokine profiles in tears using Luminex technology,” Molecular Vision, vol. 18, pp. 2717–2725, 2012. View at Google Scholar · View at Scopus
  21. E. Uchino, S. Sonoda, K. Nakao, and T. Sakamoto, “Alteration of tear cytokine balance by eye closure: analysis by multicytokine assay,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 244, no. 6, pp. 747–749, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Li, N. Wang, J. Zheng et al., “Characterization of human tear proteome using multiple proteomic analysis techniques,” Journal of Proteome Research, vol. 4, no. 6, pp. 2052–2061, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. X. Cui and G. A. Churchill, “Statistical tests for differential expression in cDNA microarray experiments,” Genome Biology, vol. 4, no. 4, article 210, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. C. A. Churchill, “Using ANOVA to analyze microarray data,” BioTechniques, vol. 37, no. 2, pp. 173–175, 2004. View at Google Scholar
  25. H.-B. Kim, C.-K. Kim, K. Iijima, T. Kobayashi, and H. Kita, “Protein microarray analysis in patients with asthma: elevation of the chemokine PARC/CCL18 in sputum,” Chest, vol. 135, no. 2, pp. 295–302, 2009. View at Publisher · View at Google Scholar
  26. M. A. Zaki, A. Micera, H. Muntasser et al., “Conjunctival expression of IL9: a role for IL9 in ocular allergy?” Allergy, vol. 68, p. 97, 2013. View at Google Scholar
  27. M. Oray and E. Toker, “Tear cytokine levels in vernal keratoconjunctivitis: the effect of topical 0.05% cyclosporine a therapy,” Cornea, vol. 32, no. 8, pp. 1149–1154, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Spolski and W. J. Leonard, “The Yin and Yang of interleukin 21 in allergy, autoimmunity and cancer,” Current Opinion in Immunology, vol. 20, no. 3, pp. 295–301, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. A. M. Zicari, M. Nebbioso, A. Zicari et al., “Serum levels of IL-17 in patients with vernal keratoconjunctivitis: a preliminary report,” European Review for Medical and Pharmacological Sciences, vol. 17, no. 9, pp. 1242–1244, 2013. View at Google Scholar · View at Scopus
  30. K. Nakanishi, T. Yoshimoto, H. Tsutsui, and H. Okamura, “Interleukin-18 regulates both Th1 and Th2 responses,” Annual Review of Immunology, vol. 19, pp. 423–474, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. K.-G. Wu, T.-H. Li, C.-J. Chen, H.-I. Cheng, and T.-Y. Wang, “Correlations of serum interleukin-16, total IgE, eosinophil cationic protein and total eosinophil counts with disease activity in children with atopic dermatitis,” International Journal of Immunopathology and Pharmacology, vol. 24, no. 1, pp. 15–23, 2011. View at Google Scholar · View at Scopus
  32. A. Leonardi, P. Brun, M. Tavolato, M. Plebani, G. Abatangelo, and A. G. Secchi, “Tumor necrosis factor-alpha (TNF-alpha) in seasonal allergic conjunctivitis and vernal keratoconjunctivitis,” European Journal of Ophthalmology, vol. 13, no. 7, pp. 606–610, 2003. View at Google Scholar · View at Scopus
  33. T. Pecaric-Petkovic, S. A. Didichenko, S. Kaempfer, N. Spiegl, and C. A. Dahinden, “Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33,” Blood, vol. 113, no. 7, pp. 1526–1534, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Leonardi, P. J. Jose, H. Zhan, and V. L. Calder, “Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis,” Ophthalmology, vol. 110, no. 3, pp. 487–492, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Mrugacz, B. Zelazowska, A. Bakunowicz-Lazarczyk, M. Kaczmarski, and J. Wysocka, “Elevated tear fluid levels of MIP-1α in patients with cystic fibrosis,” Journal of Interferon and Cytokine Research, vol. 27, no. 6, pp. 491–495, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. R. A. Black, “Tumor necrosis factor-α converting enzyme,” International Journal of Biochemistry and Cell Biology, vol. 34, no. 1, pp. 1–5, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Iwata, K. Tanaka, Y. Inoue et al., “Macrophage inflammatory protein-3 alpha (MIP-3a) is a novel serum prognostic marker in patients with colorectal cancer,” Journal of Surgical Oncology, vol. 107, no. 2, pp. 160–166, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Scuri, L. Samsell, and G. Piedimonte, “The role of neurotrophins in inflammation and allergy,” Inflammation and Allergy—Drug Targets, vol. 9, no. 3, pp. 173–180, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Micera, A. Lambiase, L. Aloe, S. Bonini, F. Levi-Schaffer, and S. Bonini, “Nerve growth factor involvement in the visual system: implications in allergic and neurodegenerative diseases,” Cytokine & Growth Factor Reviews, vol. 15, no. 6, pp. 411–417, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Lambiase, S. Bonini, S. Bonini et al., “Increased plasma levels of nerve growth factor in vernal keratoconjunctivitis and relationship to conjunctival mast cells,” Investigative Ophthalmology and Visual Science, vol. 36, no. 10, pp. 2127–2132, 1995. View at Google Scholar · View at Scopus
  41. A. Leonardi, P. Brun, M. Tavolato, G. Abatangelo, M. Plebani, and A. G. Secchi, “Growth factors and collagen distribution in vernal keratoconjunctivitis,” Investigative Ophthalmology and Visual Science, vol. 41, no. 13, pp. 4175–4181, 2000. View at Google Scholar · View at Scopus
  42. J. Shoji, N. Inada, and M. Sawa, “Antibody array-generated cytokine profiles of tears of patients with vernal keratoconjunctivitis or giant papillary conjunctivitis,” Japanese Journal of Ophthalmology, vol. 50, no. 3, pp. 195–204, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. V. Dolgachev, M. Thomas, A. Berlin, and N. W. Lukacs, “Stem cell factor-mediated activation pathways promote murine eosinophil CCL6 production and survival,” Journal of Leukocyte Biology, vol. 81, no. 4, pp. 1111–1119, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Leonardi, P. Brun, G. Abatangelo, M. Plebani, and A. G. Secchi, “Tear levels and activity of matrix metalloproteinase (MMP)-1 and MMP-9 in vernal keratoconjunctivitis,” Investigative Ophthalmology and Visual Science, vol. 44, no. 7, pp. 3052–3058, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Dozier, G. P. Escobar, and M. L. Lindsey, “Matrix metalloproteinase (MMP)-7 activates MMP-8 but not MMP-13,” Medicinal Chemistry, vol. 2, no. 5, pp. 523–526, 2006. View at Publisher · View at Google Scholar · View at Scopus